A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients

Biological Psychiatry

Volumn 45, Issue 11, 1999, Pages 1403-1411

  Bartha, Robert ^a   Al Semaan, Yousef M ^a   Williamson, Peter C ^a,b   Drost, Dick J ^a   Malla, Ashok K ^b   Carr, Tom J ^a   Densmore, Maria ^b   Canaran, Gita ^b   Neufeld, Richard W J ^b  

^a ST JOSEPH S HEALTH CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Mesial temporal; Proton Magnetic Resonance Spectroscopy; Schizophrenia

Indexed keywords

GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN LEVEL; BRAIN SIZE; BRAIN WATER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; TEMPORAL LOBE; WHITE MATTER;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ASPARTIC ACID; CASE-CONTROL STUDIES; FEMALE; FOURIER ANALYSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NEURAL PATHWAYS; PROTONS; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 0032852856     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00007-4     Document Type: Article

References (55)

1. Andreasen N.C. Scale for the Assessment of Negative Symptoms (SANS). 1994;University of Iowa, Iowa City, Iowa.
2. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS). 1994;University of Iowa, Iowa City, Iowa.
3. Andreasen N.C., Ehrhardt J.C., Swayze V.W., et al. Magnetic resonance imaging of the brain in schizophrenia The pathophysiologic significance of structural abnormalities . Arch Gen Psychiatry. 47:1990;35-44.
4. Arnold S.E., Franz B.R., Gur R.C., et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry. 152:1995;738-748.
5. 1H MR spectra: Prior-knowledge, peak elimination, filtering. NMR in Biomedicine.
6. Bartha R., Williamson P.C., Drost D.J., et al. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls using proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 54:1997;959-965.
7. 1H NMR spectra of human brain. Magn Reson Med. 32:1994;294-302.
8. Bertolino A., Callicott J.H., Elman I., et al. Regionally specific neuronal pathology in untreated patients with schizophrenia A proton magnetic resonance spectroscopic imaging study . Biol Psychiatry. 43:1998;641-648.
9. Bertolino A., Callicott J.H., Nawroz S., et al. Reproducibility of proton magnetic resonance spectroscopic imaging in patients with schizophrenia. Neuropsychopharmacology. 18:1998;1-9.
10. Bertolino A., Nawroz S., Mattay V.S., et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 153:1996;1554-1563.
11. Bilken D.L., Oldendorf W.H. N-acetyl-L-aspartic acid A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain . Neurosci Biobehav Rev. 13:1989;23-31.
12. Bogerts B. Recent advances in neuropathology of schizophrenia. Schizophr Bull. 19:1993;431-445.
13. Bogerts B., Falkai P., Haupts M. Post-mortem volume measurement of limbic system and basal ganglia structures in chronic schizophrenia. Schizophr Res. 3:1990;295-301.
14. Bryden P. Measuring Handedness with Questionnaires. Neuropsychologia. 15:1977;617-624.
15. 1H magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia Clinical, neurodevelopmental and cognitive correlates . Biol Psychiatry. 36:1994;792-800.
16. Christiansen P., Henriksen O., Stubgaard M., Gideon P., Larsson H.B.W. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Mag Reson Imaging. 11:1993;107-118.
17. Cohen J. The t test for means. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. 1988;19-74 Lawrence Erlbaum Associates, Hillsdale, NJ.
18. Davis J (1997): Xstatpack (copyright symbol) is a multi-purpose image quantification utility.
19. Deicken R.F., Zhou L., Schuff N., Fein G., Weiner M.W. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiatry. 43:1998;483-488.
20. Duijn J., Matson G.B., Maudsley A.A., Hugg J.W., Weiner M.W. Human brain infarction proton MR spectroscopy . Radiology. 183:1992;711-718.
21. Fleiss J. The Design and Analysis of Clinical Experiments. 1988;11 Wiley, New York.
22. Frahm J., Merboldt K.D., Hanicke W. Localized proton spectroscopy using stimulated echoes. J Magn Reson. 72:1987;502-508.
23. Frahm J., Michaelis T., Merboldt K.D., Bruhn H., Gyngell M.L., Hanicke W. Improvements in localized proton NMR spectroscopy of human brain. Water suppression, short echo times, and 1 ml resolution. J Magn Reson. 90:1990;464-473.
24. Fukuzako H., Takeuchi K., Hokazono T., et al. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia. Preliminary report. Psychiatry Res. 61:1995;193-200.
25. Haase A., Frahm J., Matthaei K.D. FLASH imaging Rapid NMR imaging using low flip angles . J Magn Reson. 67:1986;258-266.
26. Heckers S., Heinsen H., Heinsen Y.C., Beckmann H. Limbic structure and lateral ventricle in schizophrenia A quantitative postmortem study . Arch Gen Psychiatry. 47:1990;1016-1022.
27. Holshouser B.A., Komu M., Moller H.E., et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease. A multicentre pilot study. Magn Reson Med. 33:1995;589-594.
28. Hyde T.M., Ziegler J.C., Weinberger D.R. Psychiatric disturbance in metachronic leukodystrophy. Arch Neurology. 49:1992;401-406.
29. Kose U. In vivo proton spectroscopy in presence of eddy currents. Magn Reson Med. 14:1990;26-30.
30. Kreis R., Ernst T., Ross B.D. Absolute quantification of water and metabolites in the human brain. II. Metabolite concentrations. J Magn Reson B. 102:1993;9-19.
31. Larzelere R.E., Mulaik S.A. Single sample tests for many comparisons. Psychol Bull. 4:1977;557-569.
32. Lees M.C., Neufeld R.W.J. Matching the limits of clinical inference to the limits of quantitative methods A formal appeal to practice what we persistently preach . Can Psychol. 35:1994;268-282.
33. Lim K.O., Adalsteinsson E., Spielman D., Sullivan E.V., Rosenbloom M.J., Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Arch Gen Psychiatry. 55:1998;346-352.
34. Liu Z, Javaid T, Hu J, Brown TR (1994): CSI-autoshim procedures for body and surface coil. Proceedings of the Society of Magnetic Resonance 2nd Annual Meeting. San Francisco, CA: Society of Magnetic Resonance, p 1174. Abstract.
35. Maier M., Ron M.A., Barker G.J., Tofts P.S. Proton magnetic resonance spectroscopy An in vivo method of estimating hippocampal neuronal depletion in schizophrenia . Psychol Med. 25:1995;1201-1209.
36. Matalon R., Nichols K., Sebesta D., Deanching M., Gashkoff P., Casanova J. Aspartoacrylase deficiency and N-acetyl-asparatic aciduria in patients with Canavan disease. Am J Med Genetics. 29:1988;463-471.
37. McClure R.J., Keshavan M.S., Pettegrew J.W. Chemical and physiological brain imaging in schizophrenia. Psychiatry Clin North Am. 21:1998;93-122.
38. Michaelis T., Merboldt K.-D., Bruhn H., Hanicke W., Math D., Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo Quantification of localized proton MR spectra . Radiology. 187:1993;219-227.
39. Nasrallah H.A., Skinner T.E., Schmalbrock P., Robitaille P.M. Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia A pilot study . Br J Psychiatry. 165:1994;481-485.
40. Neufeld R.W.J. Some methods facilitating decision making in clinical practice. Clinical Quantitative Methods. 1977;68-89 Grune and Stratton, New York.
41. Poptani H., Gupta R.K., Roy R., Pandey R., Jain V.K., Chhabra D.K. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. Am J Neuroradiol. 16:1995;1593-1603.
42. Provencher S.W. Estimation of metabolite concentrations from localized in-vivo proton NMR spectra. Magn Reson Med. 30:1994;672-679.
43. Renshaw P.F., Yurgelun-Todd D.A., Tohen M., Gruber S., Cohen B.M. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry. 152:1995;444-446.
44. Robb RA (1990): A software system for interactive and quantitative analysis of biomedical images. In: Hohne KH, Fuchs H, Pizer SM, editors. 3D Imaging in Medicine, NATO ASI Series Volume F60. Berlin: Springer-Verlag, pp 333-361.
45. Roberts G.W., Colter N., Lofthouse R., Johnstone E.C., Crow T.J. Is there gliosis in schizophrenia? Investigation of the temporal lobe. Biol Psychiatry. 22:1987;1459-1468.
46. Ross R., Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q. 10:1994;191-247.
47. Spitzer R., Williams J. Structural Clinical Interview for DSM-III-R. 1985;New York Psychiatric Institute, New York.
48. 1H MR spectra. Magn Reson Med. 34:1995;17-24.
49. Suddath R.L., Christison G.W., Torrey E.F., Casanova M.F., Weinberger D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med. 322:1990;789-794.
50. Talairach J., Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. 1988;Thieme, New York.
51. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol. 46:1995;531-540.
52. Tsai G., Passani L.A., Slusher B.S., et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry. 52:1995;829-836.
53. Vion-Dury J., Nicoli F., Salvan A., Confort-Gouny S., Dhiver C., Cozzone P.J. Reversal of brain metabolic alteration with zidovudine detected by proton localized magnetic resonance spectroscopy. Lancet. 345:1994;60-61.
54. Weinberger D.R. Anteromedial temporal prefrontal connectivity A functional neuroanatomical system implicated in schizophrenia . Carroll B.J., Barrett J.E. Psychopathology and the Brain. 1991;25-43 Raven Press, New York.
55. Yurgelun-Todd D.A., Renshaw P.F., Gruber S.A., Ed M., Waternaux C., Cohen B.M. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr Res. 19:1996;55-59.